For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Seres Therapeutics, Inc.

USPTO Granted Patents = 28

EPO Patents = 3

Trademarks = 11

Forward Citations = 474

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

David N Cook (27 out of 30 patents)

Matthew R Henn (25 out of 28 patents)

David Arthur Berry (25 out of 87 patents)

4. John Grant Aunins (23 out of 30 patents)

5. Geoffrey Von Maltzahn (22 out of 104 patents)

6. Kevin Daniel Litcofsky (15 out of 17 patents)

7. Noubar Boghos Afeyan (13 out of 77 patents)

8. Anthony Mario D'Onofrio (12 out of 14 patents)

9. Mary-Jane Lombardo McKenzie (12 out of 13 patents)

10. Gregory McKenzie (10 out of 12 patents)

11. Brian Goodman (10 out of 12 patents)

12. Marin Vulic (9 out of 10 patents)

13. Jonathan Winkler (8 out of 9 patents)

14. Toshiro Kendrick Ohsumi (8 out of 16 patents)

15. Mary-Jane Lombardo Mckenzie (6 out of 6 patents)

Core Competencies:

Bacterial Compositions

Antibiotic Resistance

Clostridium Difficile

Cholestatic Disease

Microbial Compositions

Pathogenic Growth Inhibition

Gastrointestinal Tract

Immune System Disorders

28 patents: Sort by Forward Citations

1. 12605415 - Compositions and methods (2026-04-21),

2. 12409197 - Synergistic bacterial compositions and methods of production and use thereof (2025-09-09),

3. 12214002 - Compositions and methods for treating antibiotic resistance (2025-02-04),

4. 12083151 - Synergistic bacterial compositions and methods of production and use thereof (2024-09-10),

5. 11918612 - Synergistic bacterial compositions and methods of production and use thereof (2024-03-05),

6. 11730775 - Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof (2023-08-22),

7. 11701394 - Compositions and methods for treating cholestatic disease (2023-07-18),

8. 11666612 - Network-based microbial compositions and methods (2023-06-06),

9. 11464812 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-11),

10. 11458174 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-04),

11. 11458173 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-04),

12. 11389490 - Synergistic bacterial compositions and methods of production and use thereof (2022-07-19),

13. 11266699 - Synergistic bacterial compositions and methods of production and use thereof (2022-03-08),

14. 11185562 - Compositions and methods for inhibition of pathogenic bacterial growth (2021-11-30),

15. 10973861 - Compositions and methods (2021-04-13),

Company Overview

Seres Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative microbiome-based therapeutics. The company specializes in harnessing the power of the human microbiome to create treatments for various diseases, particularly in the areas of gastrointestinal health and immune-related conditions. By leveraging advanced research in microbiome science, Seres aims to transform the treatment landscape for patients with unmet medical needs, emphasizing a science-driven approach to therapeutic development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

28 Patents

#95 in Cambridge, MA

#715 in Massachusetts

#12,009 in US

#23,262 in the World

Cambridge, MA, United States of America

Seres Therapeutics, Inc.

Forward Citations = 474

22 inventors:

David N Cook (27 out of 30 patents)

Matthew R Henn (25 out of 28 patents)

David Arthur Berry (25 out of 87 patents)

4. John Grant Aunins (23 out of 30 patents)

5. Geoffrey Von Maltzahn (22 out of 104 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Seres Therapeutics, Inc.. Retrieved from https://idiyas.com/company/seres-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…